Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387130256> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4387130256 endingPage "135" @default.
- W4387130256 startingPage "129" @default.
- W4387130256 abstract "Abstract Genetic variations in the receptor, metabolizing enzymes and transporters may explain a part of the variation in anti-emetic response to ondansetron among cancer patients. This study assesses the role of ABCB1 genetic polymorphisms in the anti-emetic efficacy of ondansetron-based medication for cisplatin-based chemotherapy in South Indian cancer patients. The frequencies of common ABCB1 polymorphisms (rs1045642; C > T , rs1128503; C > T and rs2032582; G > T / A ) were studied in 234 South Indian cancer patients receiving cisplatin-based chemotherapy. Comparison of nausea and vomiting with respect to number of episodes and severity by Visual Analogue Scale (VAS), and Common Terminology Criteria for Adverse Events version 4.0 (CTCAEv4.0) was made across genotype groups of each polymorphism. TT genotype carriers of all three polymorphisms had significantly lesser incidence of nausea and vomiting when compared to other genotypes of the respective polymorphisms during 2-24 hours and on days 2-5. Median VAS score for nausea and vomiting was also lower for TT genotype carriers at each time point except for nausea on days 2-5 (p=0.057) of C 3435T . As per CTCAEv4.0, TT genotype carriers had less severe grade at each time point except for days 2-5 nausea (p=0.278) and vomiting (p=0.219) of C3435T and nausea on days 2-5 (p=0.068) of G2677T/A: TT genotype of ABCB1 genetic polymorphisms was associated with anti-emetic response to ondansetron-based medication in the population studied. Hence, genotyping for ABCB1 polymorphisms may be used as a tool to predict response to ondansetron." @default.
- W4387130256 created "2023-09-29" @default.
- W4387130256 creator A5002678965 @default.
- W4387130256 creator A5006594253 @default.
- W4387130256 creator A5060705240 @default.
- W4387130256 date "2023-09-01" @default.
- W4387130256 modified "2023-10-18" @default.
- W4387130256 title "Influence of <i>ABCB1</i> genetic polymorphisms on the antiemetic response to ondansetron-based medication for cisplatin-based chemotherapy in South Indian cancer patients in a tertiary care hospital" @default.
- W4387130256 cites W1993434718 @default.
- W4387130256 cites W1995925329 @default.
- W4387130256 cites W2009406712 @default.
- W4387130256 cites W2012005071 @default.
- W4387130256 cites W2022050157 @default.
- W4387130256 cites W2038275605 @default.
- W4387130256 cites W2064099934 @default.
- W4387130256 cites W2085480339 @default.
- W4387130256 cites W2093914030 @default.
- W4387130256 cites W2101487640 @default.
- W4387130256 cites W2123287399 @default.
- W4387130256 cites W2144619971 @default.
- W4387130256 cites W2160265221 @default.
- W4387130256 cites W2165001714 @default.
- W4387130256 cites W2169297542 @default.
- W4387130256 cites W2415852018 @default.
- W4387130256 doi "https://doi.org/10.2478/cipms-2023-0022" @default.
- W4387130256 hasPublicationYear "2023" @default.
- W4387130256 type Work @default.
- W4387130256 citedByCount "0" @default.
- W4387130256 crossrefType "journal-article" @default.
- W4387130256 hasAuthorship W4387130256A5002678965 @default.
- W4387130256 hasAuthorship W4387130256A5006594253 @default.
- W4387130256 hasAuthorship W4387130256A5060705240 @default.
- W4387130256 hasBestOaLocation W43871302561 @default.
- W4387130256 hasConcept C104317684 @default.
- W4387130256 hasConcept C126322002 @default.
- W4387130256 hasConcept C135763542 @default.
- W4387130256 hasConcept C143998085 @default.
- W4387130256 hasConcept C2776694085 @default.
- W4387130256 hasConcept C2777170512 @default.
- W4387130256 hasConcept C2780580376 @default.
- W4387130256 hasConcept C2780852908 @default.
- W4387130256 hasConcept C2780884295 @default.
- W4387130256 hasConcept C42219234 @default.
- W4387130256 hasConcept C54355233 @default.
- W4387130256 hasConcept C55775858 @default.
- W4387130256 hasConcept C71924100 @default.
- W4387130256 hasConcept C86803240 @default.
- W4387130256 hasConcept C90924648 @default.
- W4387130256 hasConcept C98274493 @default.
- W4387130256 hasConceptScore W4387130256C104317684 @default.
- W4387130256 hasConceptScore W4387130256C126322002 @default.
- W4387130256 hasConceptScore W4387130256C135763542 @default.
- W4387130256 hasConceptScore W4387130256C143998085 @default.
- W4387130256 hasConceptScore W4387130256C2776694085 @default.
- W4387130256 hasConceptScore W4387130256C2777170512 @default.
- W4387130256 hasConceptScore W4387130256C2780580376 @default.
- W4387130256 hasConceptScore W4387130256C2780852908 @default.
- W4387130256 hasConceptScore W4387130256C2780884295 @default.
- W4387130256 hasConceptScore W4387130256C42219234 @default.
- W4387130256 hasConceptScore W4387130256C54355233 @default.
- W4387130256 hasConceptScore W4387130256C55775858 @default.
- W4387130256 hasConceptScore W4387130256C71924100 @default.
- W4387130256 hasConceptScore W4387130256C86803240 @default.
- W4387130256 hasConceptScore W4387130256C90924648 @default.
- W4387130256 hasConceptScore W4387130256C98274493 @default.
- W4387130256 hasIssue "3" @default.
- W4387130256 hasLocation W43871302561 @default.
- W4387130256 hasOpenAccess W4387130256 @default.
- W4387130256 hasPrimaryLocation W43871302561 @default.
- W4387130256 hasRelatedWork W124840879 @default.
- W4387130256 hasRelatedWork W1824703102 @default.
- W4387130256 hasRelatedWork W196471322 @default.
- W4387130256 hasRelatedWork W1985908923 @default.
- W4387130256 hasRelatedWork W1994266890 @default.
- W4387130256 hasRelatedWork W2005287490 @default.
- W4387130256 hasRelatedWork W2037730757 @default.
- W4387130256 hasRelatedWork W2166413311 @default.
- W4387130256 hasRelatedWork W2248272576 @default.
- W4387130256 hasRelatedWork W2945244224 @default.
- W4387130256 hasVolume "36" @default.
- W4387130256 isParatext "false" @default.
- W4387130256 isRetracted "false" @default.
- W4387130256 workType "article" @default.